论文部分内容阅读
乙型肝炎病毒(hepatitis B virus,HBV)是引起乙型病毒性肝炎的病原体。我国乙型肝炎表面抗原(hepatitis B surface antigen,HbsAg)阳性有1.2亿人,慢性乙型病毒性肝炎2000万～3000万人,其中每年约30万人进展到肝硬化、肝癌[1]。严重损害了人民的身体健康。然而HBsAg(+)并不代表着疾病的活动和需要治疗,掌握患者的最佳治疗时机尤为重要。本次研究乙肝三系、HBV-DNA检测,结合肝功能和影像学检查的临床意义。
Hepatitis B virus (HBV) is the causative agent of hepatitis B virus. In China, 120 million people are positive for hepatitis B surface antigen (HbsAg) and 20 million to 30 million for chronic hepatitis B virus, of which about 300,000 people progress to cirrhosis and liver cancer each year [1]. Seriously damaged the health of the people. However, HBsAg (+) does not represent the activity of the disease and needs treatment, and it is particularly important to know the best timing of treatment for the patient. The study of hepatitis B three lines, HBV-DNA testing, combined with liver function and imaging clinical significance.